Pricing Log in Create free account

MDxHealth SA (MDXH) vs Psychemedics Corporation (PMD)

MDxHealth SA and Psychemedics Corporation are both Diagnostics & Research companies. MDxHealth SA is the larger, with a market value of $57.6M against $15.7M — 3.7× the size. MDxHealth SA grew revenue faster over the last twelve months: 21.5% against −10.9%. Psychemedics Corporation has the higher net margin (−9.45% vs −32.5%) and the lower return on invested capital (−31.4% vs −23.8%). Across the 17 metrics below, Psychemedics Corporation leads on 9 and MDxHealth SA on 8.

Valuation

Metric MDXH PMD Diagnostics & Research median
P/E n/m n/m 35.56
P/S 0.10 0.80 4.37
P/B n/m 3.05 3.06
Price to free cash flow n/m 19.46 35.76
EV/EBITDA n/m 77.29 24.35
EV/Sales 0.84 0.74 5.51
Earnings yield (342.86%) (11.99%) (1.89%)
Free cash flow yield (63.49%) 5.14% (0.15%)

Profitability

Metric MDXH PMD Diagnostics & Research median
Gross margin 63.23% 36.07% 50.89%
Operating margin (18.04%) (9.62%) (8.57%)
Net margin (32.53%) (9.45%) (6.37%)
Free cash flow margin (5.24%) 4.02% 0.00%
Return on equity 238.67% (31.54%) (2.92%)
Return on assets (27.38%) (18.03%) (6.71%)
Return on invested capital (23.77%) (31.42%) 0.00%

Growth

Metric MDXH PMD Diagnostics & Research median
Revenue growth (TTM) 21.46% (10.92%) 7.69%
EPS growth (last fiscal year) 42.24% 55.56% 25.92%
Revenue growth, 5-year CAGR 42.34% (12.18%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDXH PMD Diagnostics & Research median
Debt to equity (3.42) 0.01 0.11
Current ratio 1.15 1.82 2.02
Net debt to EBITDA (10.71) (7.26) 0.70

Dividend

Metric MDXH PMD Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric MDXH PMD Diagnostics & Research median
Market cap 57.60m 15.70m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack